血清25-羟基维生素D与骨密度之间的共享遗传结构及因果关联
该研究利用英国生物银行个体数据及欧洲人群GWAS汇总数据(血清25OHD N=417 580,估算足跟骨密度eBMD N=426 824),通过全基因组跨性状设计系统解析血清25OHD与eBMD的共享遗传结构及因果关系。整体遗传相关不显著(rg=-0.001;P=.95),但在5p11-5q11.9发现显著局部信号;两样本孟德尔随机化整体无因果关联(β=.003,95%CI -0.04至0.03;P=.93),单样本MR在男性和年长者中观察到正向因果效应。
要点
- 整体遗传相关不显著(rg=-0.001;P=.95),但5p11-5q11.9存在显著局部遗传信号。
- 两样本MR整体无因果关联(β=.003,95%CI -0.04至0.03;P=.93)。
- 单样本MR显示男性(β=.005,95%CI 0.00至0.01;P=.03)和年长者(β=.009,95%CI 0.00至0.02;P=.01)存在正向因果效应。
核心结论
- 本研究揭示提高血清25OHD水平可能对男性和65岁以上人群降低骨质疏松风险具有潜在健康益处。
- 研究揭示了血清25OHD与eBMD之间的共享遗传基础,为理解其复杂生物学通路提供了线索。
研究设计与样本
- 利用英国生物银行(UKB)队列个体水平数据及欧洲人群全基因组关联研究(GWAS)汇总数据,采用全基因组跨性状设计。
- 血清25OHD的GWAS样本量N=417 580,估算足跟骨密度(eBMD)的GWAS样本量N=426 824。
主要发现
- 整体遗传相关不显著(rg=-0.001;P=.95),但在5p11-5q11.9发现统计学显著的局部信号。
- 两样本孟德尔随机化显示整体人群无因果关联(β=.003,95%CI -0.04至0.03;P=.93)。
- 单样本孟德尔随机化显示男性正向因果效应(β=.005,95%CI 0.00至0.01;P=.03),年长者正向因果效应(β=.009,95%CI 0.00至0.02;P=.01)。
- 共鉴定49个多效性单核苷酸变异(SNV),其中4个为新变异(rs1077151、rs79873740、rs12150353、rs4760401)。
- 共95个基因-组织对存在重叠,主要富集于神经、消化、外分泌/内分泌和心血管系统;蛋白-蛋白互作分析鉴定RPS9和RPL7A为核心基因。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Despite the well-established regulatory role of vitamin D in maintaining bone health, little is known about the shared genetics and causality of the association between serum 25-hydroxyvitamin D (25OHD) and bone mineral density (BMD). OBJECTIVE: We aimed to investigate the shared genetic architecture and causal relationship between serum 25OHD and BMD, providing insights into their underlying biological mechanisms. METHODS: Leveraging individual-level data from the UK Biobank (UKB) cohort and summary-level data from the genome-wide association studies (GWASs) conducted on European individuals for serum 25OHD (N = 417 580) and estimated heel BMD (eBMD, N = 426 824), we systematically elucidated the shared genetic architecture underlying serum 25OHD and eBMD through a comprehensive genome-wide cross-trait design. RESULTS: Despite a lack of global genetic correlation (rg=-0.001; P = .95), a statistically significant local signal was discovered at 5p11-5q11.9. Two-sample mendelian randomization (MR) indicated no causal association in the overall population (β=.003, 95% CI, -0.04 to 0.03; P = .93), while positive causal effects were observed in males (β=.005, 95% CI, 0.00 to 0.01; P = .03) and older individuals (β=.009, 95% CI, 0.00∼0.02; P = .01) according to one-sample MR. A total of 49 pleiotropic single-nucleotide variations (SNVs), with 4 novel SNVs (rs1077151, rs79873740, rs12150353, and rs4760401), were identified, and a total of 95 gene-tissue pairs exhibited overlap, predominantly enriched in the nervous, digestive, exocrine/endocrine, and cardiovascular systems. Protein-protein interaction analysis identified RPS9 and RPL7A as hub genes. CONCLUSION: This study illuminates the potential health benefits of enhancing serum 25OHD levels to mitigate the risk of osteoporosis among men and individuals older than 65 years. It also unveils a shared genetic basis between serum 25OHD and eBMD, offering valuable insights into the intricate biological pathways.
引用
- Sha L, Zhang L, Zhao X, et al. Shared Genetic Architecture and Causal Relationship Between Serum 25-Hydroxyvitamin D and Bone Mineral Density. J Clin Endocrinol Metab. 2025. PMID: 39431290. doi:10.1210/clinem/dgae738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。